Tramontane Therapeutics
A gene therapy company aimed at successfully developing treatments for highly prevalent metabolic and neurodegenerative diseases affecting large population of patients.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | Acquisition | |
| Total Funding | - | ||